UCB SLAM

UCB SLAM (Selected Lymphocyte Antibody Method) is an incredibly powerful technology which lies at the heart of UCB's antibody discovery capability and enables us to produce antibodies with an extremely high affinity for their target proteins, that is, they bind to their targets very tightly.    

All UCB's therapeutic antibodies and research reagents are generated using UCB's SLAM technology. This enables us to obtain the DNA sequences of specific antibodies from individual B-lymphocytes.  Ultra high throughput screening technology is applied, so that one specific B-cell can be isolated from more than a billion B-cells in a few weeks.